Axsome Therapeutics, Inc.AXSMNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Under Pressure
Trending lower, above historical average, slight contraction.
Left:
||||
Year-over-year earnings per share growth rate
Latest
3.09%
↑ 117% above average
Average (39q)
-18.02%
Historical baseline
Range
High:81.56%
Low:-492.31%
CAGR
-7.1%
Structural decline
| Period | Value |
|---|---|
| Q3 2025 | 3.09% |
| Q2 2025 | 20.49% |
| Q1 2025 | 20.78% |
| Q4 2024 | -14.93% |
| Q3 2024 | 19.76% |
| Q2 2024 | -15.97% |
| Q1 2024 | 30.77% |
| Q4 2023 | -57.58% |
| Q3 2023 | 14.29% |
| Q2 2023 | -492.31% |
| Q1 2023 | 81.56% |
| Q4 2022 | -31.78% |
| Q3 2022 | -0.94% |
| Q2 2022 | -2.91% |
| Q1 2022 | -14.44% |
| Q4 2021 | 3.23% |
| Q3 2021 | -8.14% |
| Q2 2021 | -10.26% |
| Q1 2021 | 0.00% |
| Q4 2020 | -27.87% |
| Q3 2020 | -24.49% |
| Q2 2020 | 44.32% |
| Q1 2020 | -23.94% |
| Q4 2019 | -26.79% |
| Q3 2019 | -36.59% |
| Q2 2019 | -28.12% |
| Q1 2019 | 0.00% |
| Q4 2018 | -3.23% |
| Q3 2018 | 3.13% |
| Q2 2018 | -68.42% |
| Q1 2018 | 38.71% |
| Q4 2017 | -14.81% |
| Q3 2017 | 10.00% |
| Q2 2017 | 26.83% |
| Q1 2017 | -7.89% |
| Q4 2016 | 0.00% |
| Q3 2016 | -5.56% |
| Q2 2016 | -16.13% |
| Q1 2016 | -158.33% |
| Q4 2015 | 53.85% |